Amyris Bankruptcy Case Seeks Equity Holder Lawsuit Shield for Post-Chapter 11 Success
Biotechnology firm Amyris Inc. argued before a Delaware bankruptcy judge on January 24, 2024 that in order for it to successfully navigate its Chapter 11 case, it must thwart possible equity holder lawsuits. The future success of the company relies on this critical measure, to not only survive but thrive beyond bankruptcy. It is important…